当前位置: 首页 >> 检索结果
4021. The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study.
作者: Giuseppe Barilaro.;Carlo Della Rocca.;Alexandra Esteves.;Ricard Cervera.;Gerard Espinosa.
来源: Rheumatology (Oxford). 2023年62卷6期2211-2219页
To analyse the association between the average 'adjusted' Global APS Score (aGAPSS) over time, as a surrogate of disease activity, and change in Damage Index for APS (DIAPS) during follow-up in patients with thrombotic and non-thrombotic APS.
4022. Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study.
作者: Lars Erik Kristensen.;Mauro Keiserman.;Kim Papp.;Leslie McCasland.;Douglas White.;Wenjing Lu.;Ahmed M Soliman.;Ann Eldred.;Lisa Barcomb.;Frank Behrens.
来源: Rheumatology (Oxford). 2023年62卷6期2113-2121页
PsA is a chronic disease with heterogeneous clinical manifestations requiring treatment options with long-term efficacy and safety. In this follow-up analysis, the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or more conventional synthetic DMARDs (csDMARD-IR) were evaluated.
4023. External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab.
作者: Augusta Ortolan.;Sofia Ramiro.;Roberta Ramonda.;Désirée van der Heijde.
来源: Rheumatology (Oxford). 2023年62卷6期2257-2261页
The alternative ASDAS (altASDAS) is an index that can be used when patient global assessment is unavailable. Our aim was to test the truth and discrimination aspects according to OMERACT filter 2.0 of the altASDAS in an external cohort.
4024. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.
作者: Mrinalini Dey.;Naveen R.;Elena Nikiphorou.;Parikshit Sen.;Sreoshy Saha.;James B Lilleker.;Vishwesh Agarwal.;Sinan Kardes.;Jessica Day.;Marcin Milchert.;Mrudula Joshi.;Tamer Gheita.;Babur Salim.;Tsvetelina Velikova.;Abraham Edgar Gracia-Ramos.;Ioannis Parodis.;Albert Selva O'Callaghan.;Minchul Kim.;Tulika Chatterjee.;Ai Lyn Tan.;Ashima Makol.;Arvind Nune.;Lorenzo Cavagna.;Miguel A Saavedra.;Samuel Katsuyuki Shinjo.;Nelly Ziade.;Johannes Knitza.;Masataka Kuwana.;Oliver Distler.;Bhupen Barman.;Yogesh Preet Singh.;Rajiv Ranjan.;Avinash Jain.;Sapan C Pandya.;Rakesh Kumar Pilania.;Aman Sharma.;Manesh M Manoj.;Vikas Gupta.;Chengappa G Kavadichanda.;Pradeepta Sekhar Patro.;Sajal Ajmani.;Sanat Phatak.;Rudra Prosad Goswami.;Abhra Chandra Chowdhury.;Ashish Jacob Mathew.;Padnamabha Shenoy.;Ajay Asranna.;Keerthi Talari Bommakanti.;Anuj Shukla.;Arunkumar R Pande.;Kunal Chandwar.;John D Pauling.;Chris Wincup.;Döndü Üsküdar Cansu.;Erick Adrian Zamora Tehozol.;Jorge Rojas Serrano.;Ignacio García-De La Torre.;Nicoletta Del Papa.;Gianluca Sambataro.;Atzeni Fabiola.;Marcello Govoni.;Simone Parisi.;Elena Bartoloni Bocci.;Gian Domenico Sebastiani.;Enrico Fusaro.;Marco Sebastiani.;Luca Quartuccio.;Franco Franceschini.;Pier Paolo Sainaghi.;Giovanni Orsolini.;Rossella De Angelis.;Maria Giovanna Danielli.;Vincenzo Venerito.;Lisa S Traboco.;Leonardo Santos Hoff.;Suryo Anggoro Kusumo Wibowo.;Stylianos Tomaras.;Daman Langguth.;Vidya Limaye.;Merrilee Needham.;Nilesh Srivastav.;Akira Yoshida.;Ran Nakashima.;Shinji Sato.;Naoki Kimura.;Yuko Kaneko.;Jesús Loarce-Martos.;Sergio Prieto-González.;Albert Gil-Vila.;Raquel Arànega Gonzalez.;Hector Chinoy.;Vikas Agarwal.;Rohit Aggarwal.;Latika Gupta.; .
来源: Rheumatology (Oxford). 2023年62卷5期e147-e152页 4025. COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance.
作者: Shaun Ye Song Tan.;Aaron Mingyang Yee.;Jackie Jia Lin Sim.;Cynthia Ciwei Lim.
来源: Rheumatology (Oxford). 2023年62卷5期1757-1772页
COVID-19 infection is associated with significant morbidity in systemic lupus erythematosus but is potentially preventable by vaccination, although the impact of the myriad vaccines among SLE patients is not established. We aimed to assess the effectiveness, efficacy, acceptance and safety of COVID-19 vaccination in SLE.
4027. Brain oedema due to disseminated intravascular coagulation in a patient with adult-onset Still's disease-associated hemophagocytic lymphohistiocytosis-a case report.
作者: Georg Lorenz.;Christian Schaaf.;Philipp Moog.;Quirin Bachmann.;Florian Popp.;Jürgen Rech.;Johanna Schorr.;Carmen Gabl.;Claudius Küchle.;Claire Delbridge.;Gregor G Weirich.;Uwe Heemann.;Gerhard Schneider.;Nicole Lange.;Matias Wagner.;Wiebke Berg-Johnson.
来源: Rheumatology (Oxford). 2023年62卷6期e188-e190页 4028. Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis.
作者: Mrinalini Dey.;Mariam Al-Attar.;Leticia Peruffo.;Ashley Coope.;Sizheng Steven Zhao.;Stephen Duffield.;Nicola Goodson.
来源: Rheumatology (Oxford). 2023年62卷5期1740-1756页
Prompt diagnosis of septic arthritis (SA) in acute native hot joints is essential for avoiding unnecessary antibiotics and hospital admissions. We evaluated the utility of synovial fluid (SF) and serum tests in differentiating causes of acute hot joints.
4030. Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus.
作者: Ken-Ei Sada.;Yoshia Miyawaki.;Kenta Shidahara.;Shoichi Nawachi.;Yu Katayama.;Yosuke Asano.;Keigo Hayashi.;Keiji Ohashi.;Eri Katsuyama.;Takayuki Katsuyama.;Mariko Takano-Narazaki.;Yoshinori Matsumoto.;Nao Oguro.;Yuichi Ishikawa.;Natsuki Sakurai.;Chiharu Hidekawa.;Ryusuke Yoshimi.;Dai Kishida.;Takanori Ichikawa.;Yasuhiro Shimojima.;Noriaki Kurita.;Nobuyuki Yajima.
来源: Rheumatology (Oxford). 2023年62卷6期2154-2159页
Although personality characteristics of patients with SLE affect their disease activity and damage, it is unclear whether those of attending physicians affect the outcomes of patients with SLE. Grit is a personality trait for achieving long-term goals that may influence the decision-making for continuing treatment plans for patients. We aimed to evaluate the relationship between the grit of attending physicians and achievement of treatment goals in patients with SLE.
4031. COP27 Climate Change Conference: urgent action needed for Africa and the world.
作者: Lukoye Atwoli.;Gregory E Erhabor.;Aiah A Gbakima.;Abraham Haileamlak.;Jean-Marie Kayembe Ntumba.;James Kigera.;Laurie Laybourn-Langton.;Bob Mash.;Joy Muhia.;Fhumulani Mavis Mulaudzi.;David Ofori-Adjei.;Friday Okonofua.;Arash Rashidian.;Maha El-Adawy.;Siaka Sidibé.;Abdelmadjid Snouber.;James Tumwine.;Mohammad Sahar Yassien.;Paul Yonga.;Lilia Zakhama.;Chris Zielinski.
来源: Rheumatology (Oxford). 2023年62卷5期1721-1723页 4033. The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis.
作者: Helga Westerlind.;Alf Kastbom.;Johan Rönnelid.;Monika Hansson.;Lars Alfredsson.;Linda Mathsson-Alm.;Guy Serre.;Martin Cornillet.;Rikard Holmdahl.;Karl Skriner.;Holger Bang.;Lars Klareskog.;Saedis Saevarsdottir.;Karin Lundberg.;Caroline Grönwall.;Johan Askling.
来源: Rheumatology (Oxford). 2023年62卷6期2106-2112页
To assess the association between venous thromboembolic (VTE) events and autoantibodies, following patients from RA diagnosis, measuring occurrence, levels and collective load of different autoantibodies against post-translational protein modifications, in particular recognizing citrullination (e.g. citrullinated fibrinogen) and RF by isotype.
4034. Angiotensin receptor blockade is associated with increased risk of giant cell arteritis.
作者: Sizheng Steven Zhao.;Houchen Lyu.;Chao Zeng.;Guanghua Lei.;Jie Wei.;Sarah L Mackie.
来源: Rheumatology (Oxford). 2023年62卷6期2203-2210页
Angiotensin II is implicated in GCA pathology. We examined whether the use of angiotensin receptor blockers (ARBs) is associated with GCA risk compared with angiotensin-converting enzyme inhibitors (ACEis) or other antihypertensives.
4035. Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis.
作者: Federica M Ucci.;Serena Recalchi.;Cristiana Barbati.;Valeria Manganelli.;Antonella Capozzi.;Gloria Riitano.;Giorgia Buoncuore.;Tina Garofalo.;Fulvia Ceccarelli.;Francesca R Spinelli.;Eugenia Balbinot.;Alessandra Ida Celia.;Agostina Longo.;Cristiano Alessandri.;Roberta Misasi.;Maurizio Sorice.;Fabrizio Conti.
来源: Rheumatology (Oxford). 2023年62卷6期2312-2319页
To investigate the expression of citrullinated and carbamylated proteins in extracellular microvesicles (EMVs) from RA patients.
4036. Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study.
作者: Karin Wadström.;Lennart T H Jacobsson.;Aladdin J Mohammad.;Kenneth J Warrington.;Eric L Matteson.;Magnus E Jakobsson.;Carl Turesson.
来源: Rheumatology (Oxford). 2023年62卷6期2304-2311页
To investigate the relation between biomarkers of inflammation and subsequent development of GCA.
4037. Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF.
作者: Ai Yaku.;Yuki Ishikawa.;Takeshi Iwasaki.;Ryosuke Hiwa.;Keitaro Matsuo.;Hiroh Saji.;Kimiko Yurugi.;Yasuo Miura.;Moritoshi Furu.;Hiromu Ito.;Takao Fujii.;Taira Maekawa.;Motomu Hashimoto.;Koichiro Ohmura.;Tsuneyo Mimori.;Chikashi Terao.
来源: Rheumatology (Oxford). 2023年62卷5期2015-2020页
HLA-DRB1 alleles, particularly the shared epitope (SE) alleles, are strongly associated with RA. Different genetic structures underlie the production of the various autoantibodies in RA. While extensive genetic analyses have been conducted to generate a detailed profile of ACPA, a representative autoantibody in RA, the genetic architecture underlying subfractions of RF other than IgM-RF, namely IgG-RF, known to be associated with rheumatoid vasculitis, is not well understood.
4038. Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.
作者: Nadège Cordel.;Benoît Dechelotte.;Fabienne Jouen.;Janine A Lamb.;Hector Chinoy.;Paul New.;Jiri Vencovsky.;Herman Mann.;Angeles S Galindo-Feria.;Lara Dani.;Albert Selva-O'Callaghan.;Victoria P Werth.;Adarsh Ravishankar.;Océane Landon-Cardinal.;Benoit Tressières.;Olivier Boyer.
来源: Rheumatology (Oxford). 2023年62卷4期1711-1715页
To assess the role of the anti-TIF1γ auto-antibody (aAb) IgG2 isotype as a biomarker of cancer in anti-TIF1γ aAb-positive adult DM.
4039. Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination.
作者: Leher Gumber.;Nancy Gomez.;Georgina Hopkins.;Davis Tucis.;Laura Bartlett.;Kieran Ayling.;Kavita Vedhara.;Graham Steers.;Mithun Chakravorty.;Megan Rutter.;Hannah Jackson.;Patrick Tighe.;Alastair Ferraro.;Sheila Power.;Marie-Josèphe Pradère.;David Onion.;Peter C Lanyon.;Fiona A Pearce.;Lucy Fairclough.
来源: Rheumatology (Oxford). 2023年62卷6期2294-2303页
Coronavirus 2019 vaccine responses in rare autoimmune rheumatic diseases (RAIRDs) remain poorly understood; in particular there is little known about whether people develop effective T cell responses. We conducted an observational study to evaluate the short-term humoral and cell-mediated T cell response after the second severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in RAIRD patients compared with healthy controls (HCs).
4040. SNP-based heritability estimates of gout and its subtypes determined by genome-wide association studies of clinically defined gout.
作者: Yu Toyoda.;Masahiro Nakatochi.;Akiyoshi Nakayama.;Yusuke Kawamura.;Hirofumi Nakaoka.;Kenji Wakai.;Keitaro Matsuo.;Hirotaka Matsuo.; .
来源: Rheumatology (Oxford). 2023年62卷5期e144-e146页 |